Cambridge University Warns About Weil's Risk to Students
Submitted by Ria Patel on Wed, 06/29/2011 - 07:49A suspected case of life-threatening Weil's disease has caught the attention of the medical community recently. In addition, a large number of cases from Cambridge University have been reported of diarrhea and vomiting.
Scientists Discover New Strain of MRSA
Submitted by Amit Pathania on Sat, 06/04/2011 - 07:14Scientists in the UK have discovered a new strain of MRSA (methicillin-resistant Staphylococcus aureus) in cows' milk while studying the udder infection, mastitis in dairy herds. The scientists have claimed that this is the first type when any type of MRSA has been found on British farms. Early tests have revealed that the new strain has spread to nearly 3% of dairy farms in the UK.
Diabetics at a Risk of Shorter Life Expectancy
Submitted by Amit Pathania on Thu, 03/03/2011 - 10:49According to a recent study conducted by the researchers of the University of Cambridge, having diabetes in middle-age could lead to the reduction of life expectancy by six years.
The study particularly pointed out the Type-2 diabetes and several risks associated with it including cancer and infection.
Study: Total number of stars may be three-fold more than earlier estimates
Submitted by Ethan Oliveira on Thu, 12/02/2010 - 06:39In a statement that underscores that the number of stars in the universe has thus far been gravely undercounted, scientists said on Wednesday that there apparently are nearly three-fold more stars than what has been perceived thus far.
CSR Reports Positive Third Quarter Revenue, Share Prices Rise
Submitted by Dominic Haber on Fri, 10/30/2009 - 15:42Cambridge based wireless chip maker CSR yesterday made public its third quarter report which revealed revenue which stood at the upper end of the estimates posted. In light of the positive developments, shares of the giant chip manufacturer rose as much as 8%.
Ig Nobel prizes awarded; gas mask bra receives Public Health award!
Submitted by Medha Sood on Sat, 10/03/2009 - 18:12The 19th Ig Nobel Prize Ceremony organized by the magazine 'Annals of Improbable Research,' at Harvard University in Cambridge, US, saw those achievements being honored that "first make people laugh and then make them think." The awards were handed over by Nobel laureates.
Joule Biotechnologies to produce fuel from CO2 and sunlight
Submitted by Justin Sorkin on Tue, 07/28/2009 - 21:44Cambridge-based research firm, Joule Biotechnologies has ambitious plans to use designer microorganisms for producing transportation fuels by converting carbon dioxide and sunlight into a chemical indistinguishable from ethanol.
MIT researchers work out quick-recharge technique for lithium ion batteries
Submitted by Justin Sorkin on Fri, 03/13/2009 - 09:20Researchers at the Massachusetts Institute of Technology (MIT) in Cambridge, Massachusetts, have worked out a technique of recharging lithium ion batteries in a significantly quicker time. This implies that the new lithium battery know-how would bring about such a rapid charging of the battery that it would take only a few seconds rather than the earlier required minutes or even hours!
Desalination enterprise Oasys Water raises $10 million in Series A funding round
Submitted by Manjinder Singh on Sun, 02/22/2009 - 08:23In a case of new funding for up-and-coming desalination technologies, the Cambridge, Massachusetts-based desalination enterprise, Oasys Water, has raised $10 million in Series A funding round. Oasys - acronym for Osmotic Application Systems - is working at developing a proprietary desalination system called EO - Engineered Osmosis.
FDA clears Genzyme stem cell transplant drug
Submitted by Jason Ramsey on Wed, 12/17/2008 - 00:33MA-based biotech company Genzyme (NASDAQ: GENZ) has declared that it has got approval from FDA for a new drug for blood cancer patients. Clearance has been given for the sale of plerixafor (Mozobil) as an injectable drug for patients with a pair of deadly blood malignancies, non-Hodgkin’s lymphoma and multiple myeloma, who need transplants of blood-forming stem cells.











